PMID: 42139026

Orforglipron (Foundayo) - a second oral GLP-1 receptor agonist for weight loss.

The Medical letter on drugs and therapeutics · 2026

Vol. 68, Issue 1755, pp. 81-83

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.